Our institutional partnerships
In our desire to improve the health of our fellow citizens, our laboratory has from the outset chosen to be involved in the training of health professionals through our various training programs, our presence at numerous scientific congresses and our partnerships with various medical associations.
Our mission is to work towards improving the health and well-being of the population. For 25 years, we have therefore been committed to establishing long-term partnerships with various players in the health sector.
The objectives of these partnerships are to support healthcare professionals by helping them to improve the care of their patients, and to pass on our expertise to younger companies by working with them on the formulation of their products.
In partnership with the International Institute of Physionutrition and Phytotherapy (II2P), THERASCIENCE Laboratory is involved in the development of specific diagnostic questionnaires (dietary disorders, micronutritional and hormonal deficiencies and evaluation of emotional profiles) and complete and practical e-learning training courses: a complete training cycle in Physionutrition and Phytotherapy with 64 modules, combining theory and practical cases while favouring exchange and sharing of experience.
Our scientific partner, the European Institute of Physionutrition and Phytotherapy (IEPP), concentrates its energy on scientific research and contributes to training health professionals in the basics and fundamentals of Physionutrition and Phytotherapy. Indeed, the IEPP offers two University Diplomas (DU) in partnership with the Pharmacy UFR of Grenoble Alpes University:
- DU of Clinical and Biological Physionutrition for Doctor of Pharmacy, Doctor of Medicine, Maieuticians and Doctor of Dental Surgery
- DU of Health, Dietetics and Physionutrition for paramedical health professionals
The Resource Centre
Here again, the global, complementary and conventional approach of the Cancer Resource Centre has proven to be fully in line with our values :
- Optimizing therapeutic results in complete safety for cancer patients ;
- Improve treatment tolerance ;
- Act to better prevent and reduce the risk of the consequences and recurrences.